Minimal change disease

Common Name(s)

Minimal change disease

Minimal change disease is a kidney disorder that can lead to nephrotic syndrome, although the nephrons of the kidney look normal under a regular microscope. The most common symptom is swelling around the eyes, face, abdomen, and legs. Other features include poor appetite, weight gain, and a foamy appearance of the urine. The cause of minimal change disease is unknown, but it may occur following an allergic reaction, immunization, or viral infection. Treatment may involve the use of steroids such as prednisone. Children often respond better to this therapy than adults. Those who experience repeated relapses may benefit from the use of cytotoxic therapy, including cyclophosphamide, cyclosporine or chlorambucil.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Minimal change disease" for support, advocacy or research.

The NephCure Foundation

The NephCure Foundation is the only organization committed exclusively to support research seeking the cause of the potentially debilitating kidney disease Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic Syndrome, improve treatment and find a cure.

Last Updated: 30 Jan 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Minimal change disease" for support, advocacy or research.

The NephCure Foundation

The NephCure Foundation is the only organization committed exclusively to support research seeking the cause of the potentially debilitating kidney disease Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic Syndrome, improve treatment and find a cure.

http://www.nephcure.org

Last Updated: 30 Jan 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Minimal change disease" returned 79 free, full-text research articles on human participants. First 3 results:

Renal manifestations of human brucellosis: First report of minimal change disease.
 

Author(s): Nikolaos Sabanis, Eleni Gavriilaki, Eleni Paschou, Eleni Tsotsiou, Asterios Kalaitzoglou, Christos Kavlakoudis, Sotirios Vasileiou

Journal: Saudi J Kidney Dis Transpl. 2016 May;27(3):590-4.

 

Human brucellosis is considered a great example of the complexity of clinical manifestations possibly affecting multiple organs or systems. Renal manifestations of human brucellosis have been documented in few case reports and one case series. Herein, we present a case of Nephrotic ...

Last Updated: 24 May 2016

Go To URL
Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease.
 

Author(s): Hajeong Lee, Kyung Don Yoo, Yun Kyu Oh, Dong Ki Kim, Kook-Hwan Oh, Kwon Wook Joo, Yon Su Kim, Curie Ahn, Jin Suk Han, Chun Soo Lim

Journal: Medicine (Baltimore). 2016 Mar;95(12):e3179.

 

Minimal change disease (MCD) is a well-known benign primary glomerulonephritis because of its distinct rare tendency to progress to end-stage renal disease. However, factors associated with relapse in adults are not well known. We aimed to identify predictors of relapse in adult-onset ...

Last Updated: 26 Mar 2016

Go To URL
Glomerular Immune Deposits Are Predictive of Poor Long-Term Outcome in Patients with Adult Biopsy-Proven Minimal Change Disease: A Cohort Study in Korea.
 

Author(s): Sung Woo Lee, Mi-Yeon Yu, Seon Ha Baek, Shin-Young Ahn, Sejoong Kim, Ki Young Na, Dong-Wan Chae, Ho Jun Chin

Journal:

 

There has been little published information on risk factors for poor long-term outcome in adult biopsy-proven minimal change disease (MCD).

Last Updated: 23 Jan 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Minimal change disease" returned 11 free, full-text review articles on human participants. First 3 results:

Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.
 

Author(s): Andreas Kronbichler, Annette Bruchfeld

Journal: Nephron Clin Pract. 2014 ;128(3-4):277-82.

 

Treatment of nephrotic syndrome due to minimal change disease and focal segmental glomerulosclerosis remains a challenge since steroid dependence, steroid resistance and a relapsing disease course exhibits a high cumulative steroid dosage. The necessity of using alternative steroid-sparing ...

Last Updated: 9 Feb 2015

Go To URL
The treatment of minimal change disease in adults.
 

Author(s): Jonathan Hogan, Jai Radhakrishnan

Journal: J. Am. Soc. Nephrol.. 2013 Apr;24(5):702-11.

 

Minimal change disease (MCD) is the etiology of 10%-25% of cases of nephrotic syndrome in adults. The mainstay of treatment for adult MCD, oral glucocorticoids, is based on two randomized controlled trials and extensive observational data in adults, and this treatment leads to remission ...

Last Updated: 1 May 2013

Go To URL
New insights into human minimal change disease: lessons from animal models.
 

Author(s): Sumant S Chugh, Lionel C Clement, Camille Mac├ę

Journal: Am. J. Kidney Dis.. 2012 Feb;59(2):284-92.

 

The pathogenesis of minimal change disease (MCD), considered to be the simplest form of nephrotic syndrome, has been one of the major unsolved mysteries in kidney disease. In this review, recent landmark studies that have led to the unraveling of MCD are discussed. A recent study ...

Last Updated: 16 Jan 2012

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
 

Status: Recruiting

Condition Summary: Minimal Change Disease

 

Last Updated: 2 Aug 2016

Go to URL
A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome
 

Status: Recruiting

Condition Summary: Minimal Change Nephrotic Syndrome (MCNS); MCNS

 

Last Updated: 27 Oct 2015

Go to URL
Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study
 

Status: Recruiting

Condition Summary: Nephrosis, Lipoid

 

Last Updated: 25 Oct 2016

Go to URL